Pier Capital, LLC Ptc Therapeutics, Inc. Transaction History

Pier Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$46.8 - $68.92 $3.36 Million - $4.95 Million	-71,873 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $216,683 - $305,597	-4,518 Reduced 5.91%	71,873 $4.39 Million
Q3 2020 Nov 13, 2020	SELL	$45.41 - $57.07 $1.86 Million - $2.34 Million	-41,057 Reduced 34.96%	76,391 $3.57 Million
Q2 2020 Aug 13, 2020	BUY	$42.56 - $54.98 $1.25 Million - $1.62 Million	29,395 Added 33.38%	117,448 $5.96 Million
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $376,301 - $690,060	11,625 Added 15.21%	88,053 $3.93 Million
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $2.46 Million - $3.83 Million	76,428 New	76,428 $3.67 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.23B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.